Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05507008 · ClinicalTrials.gov registry record · NA

Ketone Supplementation in Eating Disorders

A NA study of Anorexia Nervosa and Bulimia Nervosa, sponsored by University of California, San Diego.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05507008: Active NA study of Anorexia Nervosa and Bulimia Nervosa, sponsored by University of California, San Diego.

NCT05507008 is a NA study of Anorexia Nervosa and Bulimia Nervosa that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 40 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05507008, a NA study of Anorexia Nervosa and Bulimia Nervosa, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the effects of ketone supplementation on eating behavior including drive to binge eat or restrict, mood and anxiety in individuals with anorexia or bulimia nervosa. In addition, the investigators will contrast the effects of active ketone supplementation versus placebo on electroencephalogram (EEG) measurement. All subjects enrolled in the study will undergo EEG on two consecutive days at the beginning of the study, after active ketone supplementation or placebo drink, matched in taste to the ketone drink. Days will be randomized. Thereafter, all subjects will take the ketone supplementation drink for two weeks, twice daily.

Primary Outcome

The Eating Disorders Inventory 3 is a self report assessment that measures core eating disorder symptoms. Subjects will complete this measure at the beginning and end of the study and the investigator will measure the change in scores. The Drive for Thinness Subscale has a range of 0 to 28 where higher scores mean worse outcome.

Interventions

  • DIETARY_SUPPLEMENT Kenetik Ketone Drink

Study Locations (1)

California

  • University of California San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-10-13
Est. Completion 2026-12-30
Phase NA
University of California, San Diego

775 total trials

What the registry record for NCT05507008 still lists

NCT05507008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Kenetik Ketone Drink is the first listed.

NCT05507008 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05507008 about?

NCT05507008 is a clinical study titled "Ketone Supplementation in Eating Disorders". This study will investigate the effects of ketone supplementation on eating behavior including drive to binge eat or restrict, mood and anxiety in individuals with anorexia or bulimia nervosa. In addition, the investigators will contrast the effects of active ketone supplementation versus placebo on...

What is the current status of trial NCT05507008?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-10-13. Estimated completion is 2026-12-30.

What conditions does trial NCT05507008 study?

This clinical trial studies the following conditions: Anorexia Nervosa, Bulimia Nervosa, Atypical Anorexia Nervosa, Atypical Bulimia Nervosa.

What interventions are being tested in trial NCT05507008?

The interventions under investigation include: Kenetik Ketone Drink (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05507008?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05507008 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05507008's enrollment target sits among peer trials

40 23rd of 43 higher than 18 of 43 other Anorexia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05507008, the US trial registry maintained by the National Library of Medicine. NCT05507008 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.